Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatic Artery Infusion Chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05889325
What this trial is testing

To Evaluate the Performance of HepaSphere Transarterial Chemoembolization Combined With Hepatic Arterial Infusion Chemotherapy on Unresectable Colorectal Liver Metastases

Who this might be right for
Colorectal Liver Metastases (CRCLM)
Peking University Cancer Hospital & Institute 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07684040
What this trial is testing

Combination Therapy in Patients With Resectable Liver Cancer

Who this might be right for
Liver Cancer (Primary and Metastatic)
Affiliated Hospital of Guangdong Medical University 68
Large-scale testing (Phase 3)UnknownNCT03780049
What this trial is testing

HAIC Plus H101 vs HAIC Alone for Unresectable HCC at BCLC A-B

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 304
Large-scale testing (Phase 3)Looking for participantsNCT06492395
What this trial is testing

Lenvatinib Plus DEB-TACE and HAIC vs. Lenvatinib Plus DEB-TACE for Large HCC With PVTT

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University 178
Testing effectiveness (Phase 2)UnknownNCT04135690
What this trial is testing

HAIC Plus Toripalimab vs. HAIC Plus Sorafenib for HCC With PVTT: a Non-comparative, Prospective, Randomized Trial

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 60
Testing effectiveness (Phase 2)Study completedNCT05348811
What this trial is testing

HAIC Combined With Donafenib and Sintilimab for Unresectable ICC

Who this might be right for
Cholangiocarcinoma
Zhongda Hospital 25
Testing effectiveness (Phase 2)Looking for participantsNCT07560488
What this trial is testing

Ipilimumab N01 Combined With Sintilimab, Bevacizumab Biosimilar, and Hepatic Arterial Infusion Chemotherapy as Conversion Therapy for Unresectable Intermediate-Advanced Hepatocellular Carcinoma

Who this might be right for
HCC - Hepatocellular CarcinomaConversion Therapy
Tianjin Medical University Cancer Institute and Hospital 43
Testing effectiveness (Phase 2)Looking for participantsNCT07337460
What this trial is testing

Efficacy and Safety of Icaritin Combined With mFOLFOX in Postoperative HCC With High-risk Recurrence Factors

Who this might be right for
Hepatocellular Carcinoma (HCC)
Northern Jiangsu People's Hospital 30
Testing effectiveness (Phase 2)UnknownNCT05877001
What this trial is testing

The Safety and Efficacy of HAIC+Tislelizumab+Regorafenib in Patients With Colorectal Liver Metastases

Who this might be right for
Colorectal Liver Metastases
Peking University Cancer Hospital & Institute 20
Post-approval studies (Phase 4)Not Yet RecruitingNCT07790419
What this trial is testing

A Prospective, Single-Arm, Open-Label Clinical Study of the Efficacy and Safety of Hepatic Arterial Infusion Chemotherapy Combined With Targeted Therapy and a PD-1 Inhibitor in Patients With Postoperative Hepatocellular Carcinoma and Microvascular Invasion

Who this might be right for
Liver Cancer
Zhai Wenlong 40
Testing effectiveness (Phase 2)Study completedNCT05532319
What this trial is testing

HAIC Sequential TAE Combined With Lenvatinib and Tislelizumab in Unresectable HCC

Who this might be right for
Liver Cancer
Guangxi Medical University 64
Testing effectiveness (Phase 2)Looking for participantsNCT06737913
What this trial is testing

HAI or IV of Adebrelimab, Combined With Bevacizumab and HAI of FOLFOX for Advanced Unresectable Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular Carcinoma (HCC)
Sun Yat-sen University 76
Testing effectiveness (Phase 2)Study completedNCT04044313
What this trial is testing

HAIC Plus Lenvatinib and Toripalimab for Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Shi Ming 36
Not applicableUnknownNCT06505486
What this trial is testing

GEMOX-HAIC Plus GEM-SYS in Combination With Lenvatinib and PD-1 Inhibitor for Large Unresectable ICC

Who this might be right for
Intrahepatic Cholangiocarcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 21
Large-scale testing (Phase 3)UnknownNCT05866172
What this trial is testing

HAIC Combined Withzoledronic Acid for the Prevention of Bone Metastases in Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 264
Large-scale testing (Phase 3)UnknownNCT04667351
What this trial is testing

HAIC of Oxaliplatin, and 2400 mg/m² 5-fu vs HAIC of Oxaliplatin, and 1200 mg/m² 5-fu for Unresectable HCC: a Randomised Phase 3 Non-inferiority Trial

Who this might be right for
HepatoCellular Carcinoma
Sun Yat-sen University 400
Testing effectiveness (Phase 2)UnknownNCT06285019
What this trial is testing

Modified TOMOX-HAIC in Combination With Sintilimab and Bevacizumab Biosimilar for First-line Treatment of Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Fudan University 65
Testing effectiveness (Phase 2)WithdrawnNCT03069950
What this trial is testing

Study of Chemotherapy With or Without Hepatic Arterial Infusion for Patients With Unresectable Metastatic Colorectal Cancer to the Liver

Who this might be right for
Colorectal Adenocarcinoma Metastatic to the Liver
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07557914
What this trial is testing

Epalrestat Combined With HAIC, Donafenib and Tislelizumab as First-line Treatment for Patients With Unresectable HCC and Diabetes

Who this might be right for
HCC - Hepatocellular CarcinomaDiabetes
Haibo Shao 32
Testing effectiveness (Phase 2)Study completedNCT06071052
What this trial is testing

TACE Plus HAIC Combined With Regorafenib for Liver Metastasis of Colorectal Cancer Refractory to Standard Treatment Regimens

Who this might be right for
Liver Metastasis Colon Cancer
First Affiliated Hospital, Sun Yat-Sen University 21
Next Page